Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 96,699
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12595303 | Antibodies and chimeric antigen receptors that target TACI | 🖼🧊📄§ | 2026-04-07 | 2040-06-04 | 0 | 31 |
| 12595258 | Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer | 🖼🧊📄§ | 2026-04-07 | 2045-04-15 | 0 | 31 |
| 12595470 | Engineered nucleases that target human and canine factor VIII genes as a treatment for hemophilia A | 🖼🧊📄§ | 2026-04-07 | 2044-02-23 | 0 | 31 |
| 12595310 | Compositions and methods for transferrin receptor 1 targeting | 🖼🧊📄§ | 2026-04-07 | 2040-11-06 | 0 | 31 |
| 12594577 | Rotary reactor for deposition of films onto particles | 🖼🧊📄§ | 2026-04-07 | 2042-10-21 | 0 | 31 |
| 12595358 | Enhancement of rubber by heat-assisted migration from ancillary rubber | 🖼🧊📄§ | 2026-04-07 | 2043-06-05 | 0 | 31 |
| 12594261 | Use of heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases | 🖼🧊📄§ | 2026-04-07 | 2039-12-14 | 0 | 31 |
| 12594256 | A19-144, A2-73 and certain anticholinesterase inhibitor compositions and method for anti-seizure therapy | 🖼🧊📄§ | 2026-04-07 | 2043-05-18 | 0 | 31 |
| 12594329 | Virus-like particles | 🖼🧊📄§ | 2026-04-07 | 2041-11-09 | 0 | 31 |
| 12594028 | EEG montage for facilitating selection of drug treatment in patients suffering from psychiatric disorders | 🖼🧊📄§ | 2026-04-07 | 2045-02-06 | 0 | 31 |
| 12594223 | Gradient composition zirconia dental materials | 🖼🧊📄§ | 2026-04-07 | 2039-08-16 | 0 | 31 |
| 12594350 | CD8-specific capture agents, compositions, and methods of using and making | 🖼🧊📄§ | 2026-04-07 | 2037-04-04 | 0 | 31 |
| 12595212 | Two-stage sintering method for preparing porous biphasic calcium phosphate ceramic from calcium-containing biological waste | 🖼🧊📄§ | 2026-04-07 | 2042-07-27 | 0 | 31 |
| 12595492 | Rapamycin resistant cells | 🖼🧊📄§ | 2026-04-07 | 2044-04-10 | 0 | 31 |
| 12594249 | Soluble curcumin and its derivatives | 🖼🧊📄§ | 2026-04-07 | 2044-06-03 | 0 | 31 |
| 12594226 | Method for promoting collagen production | 🖼🧊📄§ | 2026-04-07 | 2041-06-28 | 0 | 31 |
| 12594305 | Bone marrow microglia progenitor cells and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2040-06-04 | 0 | 31 |
| 12597496 | Dosing of incretin pathway drugs | 🖼🧊📄§ | 2026-04-07 | 2044-06-05 | 0 | 31 |
| 12595403 | Thermal energy storage compositions and methods of using the same | 🖼🧊📄§ | 2026-04-07 | 2041-01-20 | 0 | 31 |
| 12595287 | Leptospiral proteins and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2041-02-04 | 0 | 31 |
| 12594244 | Therapeutic compositions for treatment of human immunodeficiency virus | 🖼🧊📄§ | 2026-04-07 | 2045-09-29 | 0 | 31 |
| 12595462 | High throughput genetic barcoding and analysis methods | 🖼🧊📄§ | 2026-04-07 | 2041-01-14 | 0 | 31 |
| 12594346 | Crosslinked hydrogel for immune checkpoint blockade delivery | 🖼🧊📄§ | 2026-04-07 | 2041-07-08 | 0 | 31 |
| 12594269 | Method for enhancing the pharmacokinetics or increasing the plasma concentration of methyl 3-((methylsulfonyl)amino)-2-(((4-phenylcyclohexyl)oxy)methyl)piperidine-1-carboxylate or a salt thereof with an inhibitor of cytochrome P450 | 🖼🧊📄§ | 2026-04-07 | 2041-01-07 | 0 | 31 |
| 12594295 | CFTR mRNA compositions and related methods and uses | 🖼🧊📄§ | 2026-04-07 | 2042-10-24 | 0 | 31 |
| 12594284 | Combination of micronutrients to stimulate the endogenous production of hydrogen sulfide (H2S) | 🖼🧊📄§ | 2026-04-07 | 2041-05-03 | 0 | 31 |
| 12594276 | Inhibitors of human immunodeficiency virus replication | 🖼🧊📄§ | 2026-04-07 | 2045-02-03 | 0 | 31 |
| 12594283 | Mitochondria-targeted atovagone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug | 🖼🧊📄§ | 2026-04-07 | 2040-10-26 | 0 | 31 |
| 12594324 | Methods and compositions for treatment of pancreatic cancer | 🖼🧊📄§ | 2026-04-07 | 2040-06-30 | 0 | 31 |
| 12594288 | Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection | 🖼🧊📄§ | 2026-04-07 | 2043-06-05 | 0 | 31 |
| 12595483 | Treatment of tumors with miRNA targeting CDK4/CDK6 | 🖼🧊📄§ | 2026-04-07 | 2043-11-16 | 0 | 31 |
| 12594278 | Method for treatment of muscular dystrophy | 🖼🧊📄§ | 2026-04-07 | 2040-07-16 | 0 | 31 |
| 12595295 | Dosing regimes for treatment of synucleinopathies | 🖼🧊📄§ | 2026-04-07 | 2040-07-23 | 0 | 31 |
| 12595280 | Phosphoramidates for the treatment of hepatitis B virus | 🖼🧊📄§ | 2026-04-07 | 2044-04-11 | 0 | 31 |
| 12595285 | LMP-1 expressing cells and methods of use thereof | 🖼🧊📄§ | 2026-04-07 | 2042-05-13 | 0 | 31 |
| 12595250 | Substituted pyrimidine compounds as multifunctional radical quenchers and their uses | 🖼🧊📄§ | 2026-04-07 | 2042-06-15 | 0 | 31 |
| 12595243 | Modulators of extracellular signal-regulated kinase | 🖼🧊📄§ | 2026-04-07 | 2044-10-18 | 0 | 31 |
| 12594272 | 2-bromo-lysergic acid diethylamide for substance abuse | 🖼🧊📄§ | 2026-04-07 | 2041-03-25 | 0 | 31 |
| 12595300 | Anti-human P40 protein domain antibody and use thereof | 🖼🧊📄§ | 2026-04-07 | 2040-07-28 | 0 | 31 |
| 12595293 | Anti-follicle stimulating hormone receptor antibodies | 🖼🧊📄§ | 2026-04-07 | 2039-08-09 | 0 | 31 |
| 12595232 | DRG-MDM2-1 for use as a novel Mouse Double Minute 2 (MDM2) inhibitor | 🖼🧊📄§ | 2026-04-07 | 2041-02-16 | 0 | 31 |
| 12595302 | CLDN18.2 binding molecule | 🖼🧊📄§ | 2026-04-07 | 2040-05-21 | 0 | 31 |
| 12595517 | Method to treat and stratify a patient suffering from a cancer | 🖼🧊📄§ | 2026-04-07 | 2041-09-13 | 0 | 31 |
| 12594308 | Methods of preparing a postbiotic composition | 🖼🧊📄§ | 2026-04-07 | 2044-10-08 | 0 | 31 |
| 12594320 | Method for treating checkpoint inhibitors induced adverse events | 🖼🧊📄§ | 2026-04-07 | 2040-02-03 | 0 | 31 |
| 12594234 | Use of an epilobium fleischeri extract | 🖼🧊📄§ | 2026-04-07 | 2041-09-17 | 0 | 31 |
| 12595307 | Anti-CTLA4 monoclonal antibodies and chimeric antigen receptors | 🖼🧊📄§ | 2026-04-07 | 2041-06-09 | 0 | 31 |
| 12594254 | Intranasal administration of n-acetylcysteine and uses thereof | 🖼🧊📄§ | 2026-04-07 | 2043-02-07 | 0 | 31 |
| 12594245 | Dry powder formulations for messenger RNA | 🖼🧊📄§ | 2026-04-07 | 2042-05-16 | 0 | 31 |
| 12594224 | Oral care compositions and methods of use | 🖼🧊📄§ | 2026-04-07 | 2042-09-23 | 0 | 31 |